Susquehanna International Group’s Biolase, Inc. BIOL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-36,649
| Closed | -$6.96K | – | 13512 |
|
|
2024
Q1 | $6.96K | Buy |
+36,649
| New | +$17.9K | ﹤0.01% | 11939 |
|
|
2020
Q3 | – | Sell |
-10
| Closed | -$11K | – | 11297 |
|
|
2020
Q2 | $11K | Buy |
+10
| New | +$11.4K | ﹤0.01% | 9978 |
|
|
2019
Q1 | – | Sell |
-5
| Closed | -$13K | – | 10063 |
|
|
2018
Q4 | $13K | Buy |
+5
| New | +$16.1K | ﹤0.01% | 8728 |
|
|
2018
Q2 | – | Sell |
-3
| Closed | -$16K | – | 10613 |
|
|
2018
Q1 | $16K | Buy |
3
+1
| +50% | +$5.62K | ﹤0.01% | 9152 |
|
|
2017
Q4 | $8K | Buy |
+2
| New | +$14.1K | ﹤0.01% | 9125 |
|
|
2017
Q3 | – | Sell |
-4
| Closed | -$49K | – | 9795 |
|
|
2017
Q2 | $49K | Buy |
+4
| New | +$59.4K | ﹤0.01% | 8895 |
|
|
2016
Q3 | – | Sell |
-1
| Closed | -$16K | – | 9192 |
|
|
2016
Q2 | $16K | Sell |
1
-2
| -67% | -$31.6K | ﹤0.01% | 8396 |
|
|
2016
Q1 | $43K | Buy |
+3
| New | +$37.6K | ﹤0.01% | 8695 |
|
|
2014
Q4 | – | Sell |
-1
| Closed | -$25K | – | 10201 |
|
|
2014
Q3 | $25K | Sell |
1
-2
| -67% | -$56.6K | ﹤0.01% | 9312 |
|
|
2014
Q2 | $76K | Buy |
3
+2
| +200% | +$51.1K | ﹤0.01% | 9509 |
|
|
2014
Q1 | $32K | Hold |
1
| – | – | ﹤0.01% | 8755 |
|
|
2013
Q4 | $36K | Hold |
1
| – | – | ﹤0.01% | 8846 |
|
|
2013
Q3 | $23K | Buy |
+1
| New | +$32.2K | ﹤0.01% | 8314 |
|
Other funds holding BIOL
Susquehanna International Group's BIOL Position: Q2 2024 in Review
Susquehanna International Group sold out of Biolase, Inc. (BIOL) in Q2 2024, closing a stake of 36,649 shares — an estimated $6.96K sold.
Susquehanna International Group first reported a position in BIOL in Q3 2013 and held it in 13 quarters. The position peaked at $76K in Q2 2014. 2 funds tracked by Wall St. Rank hold BIOL as of Q2 2024.
- Susquehanna International Group reported no remaining Biolase, Inc. position as of Q2 2024 after selling out during the quarter.
- Susquehanna International Group sold 36,649 Biolase, Inc. shares in Q2 2024, an estimated $6.96K.
- Susquehanna International Group first reported a position in Biolase, Inc. in Q3 2013 and held it in 13 quarters.
- Susquehanna International Group's Biolase, Inc. position peaked at $76K in Q2 2014.
- 2 funds tracked by Wall St. Rank held Biolase, Inc. as of Q2 2024.
Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.